These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17981227)

  • 1. The immunology of hepatitis B.
    Vierling JM
    Clin Liver Dis; 2007 Nov; 11(4):727-59, vii-viii. PubMed ID: 17981227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immune responses in hepatitis B virus infection.
    Das A; Maini MK
    Dig Dis; 2010; 28(1):126-32. PubMed ID: 20460900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of HBV antigens and HBV DNA by dendritic cells.
    Cui GY; Diao HY
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):584-92. PubMed ID: 21134826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathogenesis of HBV infection.
    Koziel MJ
    Antivir Ther; 1998; 3(Suppl 3):13-24. PubMed ID: 10726052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.
    Tan AT; Koh S; Goh V; Bertoletti A
    J Gastroenterol Hepatol; 2008 Jun; 23(6):833-43. PubMed ID: 18565018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus gene products as immunological targets in chronic infection.
    Feitelson MA
    Mol Biol Med; 1989 Oct; 6(5):367-93. PubMed ID: 2696858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen.
    Kang EH; Kown TY; Oh GT; Park WF; Park SI; Park SK; Lee YI
    Antiviral Res; 2006 Nov; 72(2):100-6. PubMed ID: 16720052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
    Avettand-Fenoel V; Thabut D; Katlama C; Poynard T; Thibault V
    J Clin Microbiol; 2006 Jun; 44(6):2250-3. PubMed ID: 16757632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune response to a third generation hepatitis B vaccine.
    Schumann A; Fiedler M; Dahmen U; Grosse-Wilde H; Roggendorf M; Lindemann M
    J Viral Hepat; 2007 Aug; 14(8):592-8. PubMed ID: 17650294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis: role of innate and adaptive immune responses.
    Visvanathan K; Lewin SR
    Semin Liver Dis; 2006 May; 26(2):104-15. PubMed ID: 16673289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.